Skip to Content
 
Center for International Blood and Marrow Transplant Research

GV22-02

Main Content

Clinical Risk Factors Alone Do Not Predict the Development of Moderate-Severe Chronic Graft-versus-Host Disease After Hematopoietic Cell Transplantation and Post-Transplant Cyclophosphamide

Study #: GV22-02

Study Status: Published

Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide.

Citation

Im A, Wang T, DeFilipp Z, Farhadfar N, El Jurdi N, Khandelwal P, Kitko CL, Devos J, Castillo P, Ganguly S, Grunwald MR, Hamilton BK, Hashem H, Jamy O, Rangarajan HG, Kharfan-Dabaja MA, Yared JA, Williams KM, William BM, Spellman SR, Lee SJ, Pavletic S.

Bone Marrow Transplantation. 2026, Oct 29: (): . doi: 10.1038/s41409-026-03082-x. Epub 2026, Oct 29. PMCID:.

PubMed

PMID: 42957810

Abstract